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Dietary exposure to silver nitrate compared to two
forms of silver nanoparticles in rainbow trout:
bioaccumulation potential with minimal
physiological effects†
Nathaniel J. Clark, David Boyle, Benjamin P. Eynon and Richard D. Handy *
The trophic transfer of silver to fishes in aquatic food chains is a concern, but little is known about the die-
tary accumulation of pristine (Ag NPs) and modified (Ag2S NPs) forms of silver-containing nanoparticles.
The current study aimed to assess the bioaccumulation potential of these materials following dietary expo-
sure to 100 mg kg−1 Ag as either AgNO3, Ag NPs or Ag2S NPs compared to no added Ag controls. The ex-
periment consisted of a 4 week uptake phase, followed by a further 2 weeks on the control diet (total 6
weeks). Fish were sampled for total Ag analysis (weeks 1–4 and 6), plasma ions, biochemistry and histology.
The highest Ag concentrations were in the mid intestine, hind intestine, kidney, liver and gallbladder, re-
gardless of the type of silver exposure. Overall, there was significantly more Ag accumulation from AgNO3
and Ag NP exposure compared to the Ag2S NP treatment, indicating a lower bioavailability of the latter.
Following the 4 week exposure, the highest Ag concentrations (from AgNO3, Ag NPs and Ag2S NPs, re-
spectively) was in the hind intestine (140, 90, 0.5 μg g−1), liver (120, 130 and 11 μg g−1) and gallbladder (20,
40 and 1 μg g−1). The liver concentration represented around 40% of the body burden of Ag for all Ag
treatments. Following the depuration period (week 6), the Ag concentrations in the tissues showed some
transient changes. Notably, there was a significant increase in the liver Ag body burden (66, 63 and 99% for
AgNO3, Ag NPs and Ag2S NPs, respectively) in the post-exposure phase. An in chemico digestibility assay
simulating low pH in the stomach indicated some dissolution of silver, but there were equal orders of Ag
release from both the AgNO3 and Ag NP diets, and none from the Ag2S NPs. There were no treatment-
dependent differences in cumulative food intake or intestinal morphology, and only minor transient
changes in plasma ions, total glutathione and TBARS in the organs. Overall, the dietary bioaccumulation
potential of the nano forms of silver was equal to, or less than the metal salt, and with minimal toxicologi-
cal effects following 4 weeks exposure.
Introduction
The persistence in the environment, bioaccumulation poten-
tial and toxicity (PBT) are key triggers of concern for the envi-
ronmental risk assessment of chemicals, including
engineered nanomaterials (ENMs); but of these processes,
bioaccumulation has received little attention (review, Handy
et al.1). Dissolved silver is very toxic to aquatic species (re-
view, Ratte2). The uptake of total Ag from food exposures of
silver salts have been reported for freshwater fish with dietary
bioavailability typically being a few percent of the ingested
dose;3,4 in keeping with other studies on dietary metal salts
in fish (reviews,5,6). However, less is understood about the di-
etary uptake and bioaccumulation potential of ENMs in fish.1
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Environmental significance
Little is known about the trophic transfer of nano silver to fishes in aquatic food chains and there are concerns about dietary accumulation of pristine
silver nanoparticles (Ag NPs) as well as silver sulphide particles (Ag2S NPs) that are likely the most persist form in the environment. Dietary
bioaccumulation of Ag from food containing silver nitrate (AgNO3), Ag NPs, and less from food containing Ag2S NPs, was observed. There was limited
clearance of the Ag from the internal organs, indicating a bioaccumulation hazard for the materials. Overall, the dietary bioaccumulation potential of the
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The ecological concern is that the propensity of ENMs to
settle from the water column will lead to exposure of the sed-
iments and benthic species that comprise the base of food
webs; leading to subsequent dietary exposure of higher tro-
phic levels including predatory fish in the water column.7–9
This is an issue for Ag-containing ENMs, but pristine Ag NPs
can be transformed in the environment to stable, persistent
Ag2S NPs.
10–12 Indeed, sulfidation is regarded as the primary
transformation of Ag NPs during wastewater treatment,13
such that Ag2S NPs are likely the main form of release to the
aquatic environment.
There are only a few reports of dietary exposures to ENMs
in freshwater fish. For single walled carbon nanotubes14 and
TiO2 NPs,
15 the dietary bioavailability to the internal organs
appears to be small or negligible. However, this is not the
case with some other ENMs. For example, Connolly et al.16
fed rainbow trout with food containing 300 or 1000 mg kg−1
ZnO, and after 12 days the intestine and gill tissue concentra-
tions of total Zn were greater than the controls, and the ele-
vated Zn concentrations persisted in those tissues for some
weeks during a depuration phase. Interestingly, there were
only transient changes in the plasma and liver Zn concentra-
tions.16 Zebrafish (Danio rerio) exposed for 60 days to 0.8%
body weight of 4 mg kg−1 of two sizes of cadmium quantum
dots (CdS NPs; 8 or 50 nm diameter) showed elevated total
Cd concentrations in the livers from both sizes of the mate-
rial compared to the unexposed controls.17 However, a key
concern for risk assessment is whether the nano form is
more hazardous than the equivalent concentration of a metal
salt. In sea bream (Pagrus major) at least, animals fed diets
containing 4 mg kg−1 of Cu as Cu NPs or CuSO4 for 60 days
showed similar increases in total Cu concentrations in the
whole carcass and liver; although Cu dissolution and particle
characterisation was not reported.18
Recently, our laboratory explored the potential bioavail-
able fraction of total Ag released from fish food using a se-
quential extraction procedure that simulated the digestion of
food in the gut of fish.1 This in chemico digestibility assay
showed that both AgNO3 and Ag NPs have an extractable frac-
tion of Ag between 1–4% of the dose, depending on the re-
gion of the gut being simulated; and less for Ag2S NPs. This
raises the concern that ingested Ag-containing ENMs could
be available via the gut to fish and that the hazard will de-
pend on the chemical form of the ENM. The aim of the pres-
ent study was therefore to explore the in vivo dietary bio-
accumulation potential of total Ag from exposures to diets
containing AgNO3, Ag NPs or Ag2S NPs compared to
unexposed controls for rainbow trout (Oncorhynchus mykiss).
In addition, a post-exposure phase was included to inform on
the clearance of any apparent Ag accumulation by the fish.
The in chemico digestibility assay was also used to assess any
apparent dissolved Ag release from the food pellets at the
acidic pH of the stomach. Finally, it is also critical to link any
apparent bioaccumulation with biological effects, conse-
quently the health of the animals was monitored in terms of
food intake and intestinal morphology. Given the known in-
terferences of dissolved Ag with sodium homeostasis, plasma
and tissue electrolytes were also measured along with bio-
markers of oxidative stress in the tissues (total glutathione,
GSH, and thiobarbituric acid reactive substances, TBARS).
Methodology
Experimental design
Juvenile rainbow trout weighing ∼10 g (n = 350) were obtained
from Exmoor Fisheries and held for 14 days in a quarantine
tank prior to the experiment. Fish were graded and trans-
ferred into a flow through systems containing 12 glass tank
aquaria (70 L; 26 fish per tank). The water flow rate was 0.52
± 0.07 L min−1 (n = 12) and did not statistically differ (one
way ANOVA, P = 0.328) between treatments. Fish were left in
the tanks for two days prior to the experiment to settle and
form social hierarchies. Treatments were randomly assigned
to tanks (3 tanks per treatment). Fish were fed one of four di-
ets for four weeks: a control diet (no added Ag), or 100 mg
kg−1 Ag as AgNO3, Ag NP or Ag2S NPs. Following this, a two-
week depuration period occurred where all treatments were
fed the control diet. Fish were fed a 2% body weight ration
per day whereby the amount of food was altered each week
based on the tank biomass. Fish were fed carefully at approx-
imately 9 am, 1 pm and 5 pm each day and observed to en-
sure the daily ration was eaten immediately. There were no
residual food pellets in the water after each feed. The photo-
period was set to 12 h light : 12 h dark. The tanks were also
cleaned periodically, with careful siphoning of any residual
faecal matter from the tanks to ensure water quality.
Water samples were taken daily for oxygen, temperature,
pH and ammonia. Water samples for measuring total silver
concentration were collected once a week. There was no con-
sistent detectable Ag in the control or Ag2S NP treatments
(<0.10 ng mL−1; LOD). Despite monitoring the cleanliness of
the fish tanks, the AgNO3 and Ag NP treatments showed a
trace amount of total silver in the tanks that was just above
the LOD of 0.40 ± 0.04 and 0.47 ± 0.04 ng mL−1 (mean ± S.E.
M., n = 24 per treatment), respectively. No Ag was detected
during the depuration period.
Six of the stock fish were sampled at the start of the ex-
periment for reference and to determine the background tis-
sue Ag concentrations in the animals. Subsequently, fish
from the experimental tanks were sampled at weeks 1, 2, 3
and 4 during the exposure phase and at the end of the
depuration phase on clean food (week 6) for trace metal
analysis (i.e., at least 2 fish per tank equating to 6 fish per
treatment at each time point). Samples for biochemistry
and histology were taken at week 4. Blood samples were
also collected at weeks 2, 4 and 6 (see below). The entire ex-
periment was conducted with ethical approval from the UK
Home Office via a Project Licence held at Plymouth Univer-
sity under the Animals (Scientific Procedures) Act (1986),
and its amendments, in compliance with Directive 2010/63/
EU. In order to facilitate dissection and to ensure animal
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the morning of the sampling days. The last feed of the fish
was the evening before sampling, allowing time for evacua-
tion of the gut contents (∼15 h).
Nanoparticles and diet formulation
The ENMs were supplied as part of the EU NanoFase project,
and the characterisation of batches of the same materials
used here are reported elsewhere.19 Briefly, the Ag NPs and
Ag2S NPs were provided by Applied Nanoparticles (Barce-
lona). The Ag NPs were supplied (manufacture's information)
at a nominal size and concentration of 50 nm and 10.4 g L−1,
respectively. The Ag2S NPs had a nominal size and concentra-
tion of 20 nm and 9.6 g L−1, respectively. The Ag NPs were
dispersed in 25 μM tannic acid and 5.5 mM sodium citrate,
and 1 mg mL−1 polyvinylpyrrolidone (PVP), and the Ag2S NPs
were dispersed in 1 mg mL−1 PVP only. Transmission
electron microscopy (TEM, JEOL-1200EX II) was conducted at
Plymouth to confirm the primary particle diameters of the
materials. Briefly, a copper grid was placed on top of a drop
of the stock suspensions; after which the grid was removed
and allowed to dry for 10 min at room temperature before
imaging. The TEM revealed the primary particle diameter of
Ag NPs and Ag2S NPs to be 55 ± 3 nm (mean ± S.D., n = 120)
and 37 ± 19 nm (mean ± S.D., n = 103), respectively (as
reported in Clark et al.20). The concentration of the total Ag
in the stocks of Ag NPs and Ag2S NPs was also measured by
inductively coupled plasma mass spectrometry (ICP-MS,
Thermo X-series 2 ICP-MS). The stock concentrations for
(mean ± S.D., n = 4) the Ag NPs and Ag2S NPs were 9.5 ± 0.4
and 1.4 ± 0.1 g L−1.
The diet used throughout the study was a commercial fish
food (Aller Futura, EX, Kaliningrad, Russia), with a pellet size
of 1.5 mm. The proximate composition of the diets was (%
dry weight from manufacturer's guidelines): lipid, 17; pro-
tein, 58; ash, 10.1; fibre, 0.9. The intact food pellets were
supplemented with a stock dispersion of the relevant nano-
material or AgNO3 that was allowed to soak into the pellets
and this was then sealed with a topcoat of 10% gelatine; sim-
ilar to the method used in our previous dietary studies on
ENMs.21 The dosing dispersions for mixing with the diets
were prepared by sonicating (FB15048 ultrasonic bath, 35 W,
Thermo Fisher) 100 mL of a nominal stock concentration of
1 g L−1 of Ag as either AgNO3, Ag NPs and Ag2S NPs prepared
in ultrapure water for 1 h (i.e., a 1 : 10 dilution of the stock
supplied by the manufacturer). Nanoparticle tracking analysis
(NTA) was conducted to confirm the materials could be dis-
persed adequately in these stocks. The mean (± S.D.) hydro-
dynamic diameter was 73 ± 2 nm (n = 3) for 1 mg L−1 Ag NPs
and a mean hydrodynamic diameter of 124 ± 31 nm (n = 3)
for 1 mg L−1 Ag2S NPs. This was slowly added to 900 g of the
diet and thoroughly, but gently mixed with a commercial
food mixer (Kenwood KM810/KM816, 2004). A solution of 10
g of porcine gelatine (>98% purity, Sigma-Aldrich) in 100 mL
of ultrapure water was prepared by gentle heating to 40 °C,
allowed to cool for 10 minutes, and then gently poured over
the diet and mixed in for 15 minutes. The unexposed control
diet was prepared in exactly the same way, but dosed with
ultrapure water without any silver. The diets were then placed
in an incubator at 45 °C and left to dry overnight. The
expected nominal concentration in the silver-supplemented
diets was 100 mg of total Ag kg-1 dry weight of food. The total
Ag concentrations of the diets were measured by ICP-MS (see
below) with 0.72 ± 0.22, 92.35 ± 7.33, 96.19 ± 11.49 and 88.16
± 23.16 mg kg−1 dry weight (mean ± S.E.M., n = 8) in the con-
trol, AgNO3, Ag NP and Ag2S NP treatments respectively.
There was no significant difference between the Ag concen-
trations in the exposure diets (one way ANOVA, P > 0.05).
Tissue collections and blood sampling
Blood sampling and dissection followed Shaw et al.22 The ex-
perimental fish were blood sampled at weeks 2–6 (the ani-
mals were initially too small to collect blood before week 2).
For blood sampling, (n = 2 fish per tank, n = 6 per treatment)
were anaesthetised using buffered (NaHCO3) MS222, pithed
(to destroy the brain) and the whole blood removed via the
caudal vein into heparinised syringes. Then 50 μL of whole
blood was digested in 0.2 mL of concentrated nitric acid at
60 °C for 4 hours, allowed to cool and diluted to 2 mL with
ultrapure water prior to analysis for total Ag by ICP-MS (see
below). The remaining whole blood was centrifuged, and the
plasma removed and stored at −20 °C until required. The
plasma Na+ and K+ concentrations were analysed by flame
photometry (Sherwood Model 420 Flame Photometer). The
fish were then dissected for biochemical analysis (see below).
For metal analysis, the fish were dissected for the mid in-
testine, hind intestine, liver (following gallbladder removal),
kidney, spleen, gill and brain (n = 2 fish per tank, n = 6 per
treatment). The mid and hind intestine were rinsed in
ultrapure water and blotted before wet weight determination.
Care was taken to avoid cross-contamination between fish
with clean, acid-washed instruments. Tissues (0.001–0.363 g)
and carcasses (7–38 g) were freeze dried (Lablyo freeze dryer)
for 24 h and weighed. Once dried, the hind intestine, kidney
and liver, of week 2, 4 and 6 only, were cut in half; one half
was used for total Ag concentrations (and electrolytes)
reported here, and the other half for particulate analysis
(reported elsewhere). The freeze drying was primarily to dry
the samples, but the process also enabled the carcass sam-
ples to be crushed to a powder so that a sub-sample of car-
cass could then be used for acid digestion and total Ag deter-
mination (see below).
Trace metal analysis
Tissue metal analysis was similar to Shaw et al.22 with modi-
fications for silver. Tissues were freeze dried, weighed and
digested using 200 μL of analytical grade (primer plus) nitric
acid and heated using a water bath to 60 °C for 4 h. With ev-
ery analysis, procedural blanks were analysed to check for
leaching from the test tubes or other incidental contamina-
tion from the reagents (not observed, blanks remained below
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the limit of detection of the instrument). Following digestion,
the samples were diluted to 2 mL using 22.2 μg L−1 indium
and iridium spiked ultrapure water (for use as internal stan-
dards) before being analysed by ICP-MS. Drift was monitored
using the indium and iridium signals and standards were
checked after every 15 samples. The samples were matrix-
matched with the standards. The 107Ag isotope signal was
used to determine total Ag concentration. However, both
107Ag and 109Ag isotopes were measured to aid interpretation
of results from values near the limit of detection of the ICP-
MS. The limit of detection of the ICP-MS ranged between
0.04 and 0.18 ng mL−1 depending on the sample type, which
equates to between 1 and 25 ng g−1 tissue dw. In addition to
Ag determination, tissue samples from week 4 (the end of the
exposure phase) were diluted (0.5 mL sample diluted to 2.5
mL) and analysed by ICP-OES for the tissue electrolyte com-
position (Cu, Fe, Mn, Na, Ca and K) according to Shaw
et al.22
Histology examination
Fish were sampled at week 4 for histological examination
according to Al-Bairuty et al.23 Animals were randomly se-
lected (n = 2 per tank/n = 6 per treatment), euthanized (as
above) and carefully dissected to collect the second gill arch,
mid intestine, hind intestine and liver. Tissues were immedi-
ately placed in 10% buffered formal saline for at least one
week for fixation. Tissues were processed using an automated
tissue processor (Leica TP1020 semi-enclosed benchtop)
where samples were taken from the formal saline into indus-
trial methylated spirit (50–100%), followed by clearing using
histolene and then taken to wax (∼20 h total time). Tissues
were then embedded in wax blocks (Leica EG 1150H) and sec-
tioned at 6 μm intervals (Leica RM2235 microtome) and
dried overnight. For the mid and hind intestinal morphology,
slides were stained with 0.5% haematoxylin and counter-
stained with 1.1% van Gieson's to differentiate the connective
tissues, followed by 1.0% alcian blue for the mucocytes in the
epithelium. Mallory's trichrome was used for gill morphol-
ogy. Tissues were viewed and photographed using a Leica
microscope (DMD108) with a built in camera. The dimen-
sions of the mucocytes were measured manually using the
embedded software in the Leica microscope.
Biochemistry
The mid intestine, hind intestine, liver, kidney, gill and brain
were sampled at week 4 for biomarkers of oxidative stress in-
cluding the TBARS assay and total GSH according to Smith
et al.24 Following dissection, tissues were snap frozen in liq-
uid nitrogen and stored at −80 °C until required for analysis.
Tissues (approximately 0.2 g) or the whole brain were thawed
on ice and homogenised (Cat X520D with a T6 shaft, medium
speed, Bennett & Co., Weston-Super-Mare) into 1 mL of ice-
cold isotonic buffer [in mmol L−1; 300 sucrose, 0.1 ethyl-
enediaminetetraacetic acid (EDTA), 20 (4-(2-hydroxyethyl)-
piperazine-1-ethane sulfonic acid (HEPES)), adjusted to pH
7.8 with a few drops of tris (2-amino-2-hydroxymethyl-1,3-
propanediol)]. Following centrifugation (2 min at 13 000
rpm), the supernatant from the crude tissue homogenates
were stored at −80 °C until required. The samples were
analysed (in triplicate) for TBARS and total GSH.
For the TBARS assay, 130 μL of sample or standard was
added to an Eppendorf tube followed by 32.5 μL of 1 mmol
L−1 butylated hydroxytoluene (2,6-di-O-tert-butyl-4-methyl-
phenol or BHT) to prevent oxidation, 455 μL of phosphate
buffer (100 mmol L−1 potassium phosphate and 5 mM EDTA)
and then 162.5 μL of 50% (w/v) trichloroacetic acid (TCA) to
precipitate excess protein. The samples were then centrifuged
for 2 min at 13 000 rpm. Following this, 150 μL of the super-
natant was added to 3 wells in a 96-well plate, followed by
the addition of 75 μL of 1.3% TBA (in 0.3% NaOH). The plate
was covered and incubated for 60 min at 60 °C, allowed to
cool to room temperature and the absorbances measured
at 530 nm against standards (0.5–25 nmol mL−1 1,1,3,3-
tetraethoxypropane).
For total glutathione, 20 μL of sample homogenate and
140 μL of mixture containing 0.714 mmol L−1 DTNB (5,5′-
dithiobisĲ2-nitrobenzoic acid)), 100 mmol L−1 phosphate
buffer and 0.357 U mL−1 glutathione reductase into a 96-well
plate. To start the reaction, 40 μL of 1 mmol L−1 NADPH
was added to each well. The rate of change of the absor-
bance of each sample were read at 412 nm for 15 min with
readings every 15 seconds, and compared to GSH standards.
TBARS and GSH were normalised to the protein concentra-
tion of each homogenate. Protein was determined in tripli-
cate using 25 μL of sample using a commercially available
kit (Pierce BCA protein assay kit 23227, Thermo Fisher). To
check for interferences, the assays were run with the appro-
priate amount of Ag spiked into the samples at their respec-
tive tissue concentrations of total Ag. No interferences were
found.
In chemico digestibility
To aid data interpretation over the bioavailability and form of
Ag in the gut lumen of rainbow trout, an in chemico digest-
ibility assay was used.1 Two compartments of gastrointestinal
tract were simulated with artificial solutions: the stomach
(0.1 M HCl, 0.9% NaCl, pH 2) and the intestine (0.9% NaCl,
pH 7.8). The experimental diets (described above) were
placed into 15 cm sections of clean dialysis tubing (typical
pore size <2 nm) and tied closed (1 g food per bag, n = 4 rep-
licates). Samples were then incubated in 20 mL of the respec-
tive artificial gut fluid for 4 h in rotating tubes at 30 rpm
(Stuart Tube Roller SRT6) to mimic peristalsis movements.
Afterwards, the external fluid was collected for total Ag deter-
mination by ICP-MS (as above).
Calculations and statistics
For growth performance in each tank, the average body
weight of the fish in each tank was calculated each week as
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derive the body distribution of silver amongst the organs of
the fish the absolute amount of total Ag in each organ was
first calculated and then expressed as a percentage of the
body burden. The absolute mass of Ag in the organ was cal-
culated from the measured concentration in the organ (μg
g−1 dry weight) multiplied by the dry weight of the whole or-
gan. In order to determine the whole body burden, the abso-
lute mass of Ag in each of the organs was added together,
plus that of the remaining carcass. Values for each organ
were expressed as a percentage of the total body burden. All
data analysis was performed in SigmaPlot 13.0. Data were
checked for outliers using Grubb's test, following which
they were assessed for normality (Shapiro–Wilk test) and
equal variance (Brown Forsythe). Statistical differences were
assessed using either a one-way ANOVA (growth, cumulative
feed, tissue moisture and electrolyte composition, mucocyte
size, biochemical endpoints) or two-way ANOVA for analysis
treatment and time (tissue Ag concentrations, Ag body distri-
bution and in chemico digestibility). For non-parametric data,
log10 transformations were performed, or followed by a
Kruskal–Wallis test as appropriate. P values presented are
from Holm–Sidak for parametric data and either Dunn's test
or Student–Newman–Keuls test for non-parametric data.
Results
Tissue total Ag concentration in the organs
The initial stock fish were analysed for total Ag by ICP-MS
and showed trace amount of Ag in the liver tissue only
(0.43 ± 0.06 μg g−1 dw Ag, mean ± S.E.M., n = 6). The
remaining tissues had Ag concentrations that were below
the limit of detection of the instrument (<50 ng g−1 dw).
Over the 6 week experiment, the organs of the unexposed
control fish; including the spleen, brain, gills, gallbladder,
kidney, mid intestine and carcass, had no detectable total
Ag concentration. Trace amounts of Ag were found in the
hind intestine and liver of the unexposed fish, which
remained low but with some transient time-dependent
changes (Table 1).
During the 4 week exposure phase to dietary AgNO3, there
were elevated total Ag concentrations in all the organs com-
pared to the unexposed controls, with persistent increases of
total Ag concentrations found in the mid and hind intestine
in keeping with the route of exposure. The liver as a central
compartment in metal accumulation also showed a gradual
elevation of Ag with the highest total Ag concentration at
week 4 of AgNO3 diet compared to week 1 (two-way ANOVA; P
< 0.001). There were also especially elevated Ag concentra-
tions in the gallbladder, whole blood and kidney of the
AgNO3 treatment compared to the unexposed controls
(Table 1). In contrast, the gills of fish fed the AgNO3 diet
showed a steady total Ag concentration of around 1 μg g−1 dw
or less, in keeping with the organ being perfused with Ag-
containing blood rather than incidental Ag exposure via the
water. Two-way ANOVA's revealed the brain (P < 0.05) and
spleen (P < 0.05) had time-dependent increases in total Ag,
but these did not exceed 2 μg g−1 dw by the end of the expo-
sure phase. The whole blood Ag concentrations remained
constant throughout the exposure phase (two-way ANOVA; P
> 0.05).
The AgNO3 and Ag NP treatments showed a very similar
profile of total Ag concentrations in the organs and whole
blood, with no statistically significant differences between
these two treatments over the 4 weeks (Table 1). For exam-
ple, the livers of fish from both treatments at week 4
showed total Ag concentrations around 122–129 μg g−1 dw.
However, both the AgNO3 and Ag NP treatments showed
statistically significantly higher total Ag concentrations com-
pared to the Ag2S NP treatments in all tissues from week 1
to 4 (Table 1). For example, the livers (two-way ANOVA; P <
0.001) of fish from the Ag2S NP treatment showed only 11
μg g−1 dw of total Ag; an order of magnitude less Ag than
either the Ag NP or AgNO3 dietary treatments. Crucially, the
mid (P < 0.001) and hind (P < 0.001) intestine of fish from
the Ag2S NP treatment accumulated only 2 μg g
−1 dw of to-
tal Ag or much less (two-way ANOVA; Table 1), which was
10–100 fold less than the intestine of the other Ag treat-
ments and indicating that Ag from Ag2S form was the least
available for uptake by the gut. Within the Ag2S NP treat-
ment, there were no time-dependent changes in the gall-
bladder, brain or carcass concentration (P > 0.05), with
values of around 1 μg g−1 dw or less; although there were
some transient increases in the total Ag in the kidney (P <
0.03) and hind intestine (P < 0.001) during the exposure to
the Ag2S diet (two-way ANOVA; Table 1).
After the 4 weeks of exposure to the Ag-containing diets,
there was a two-week depuration phase where the fish from
all treatments were fed the unexposed control diet. In the an-
imals previously fed the AgNO3 diet, a two-way ANOVA re-
vealed there were statistically significant decreases in the to-
tal Ag concentrations in the hind intestine (P < 0.001) and
carcass (P < 0.001) at the end of the depuration phase com-
pared to the values at the end of the exposure phase (week 4,
Table 1). However, there was no appreciable clearance of Ag
from the other internal organs of fish from the AgNO3 treat-
ment, including the liver (Table 1). An identical pattern of de-
creasing, or unaltered, total Ag concentrations were found in
the organs of fish from the Ag NP treatment in the post expo-
sure phase. Despite some evidence of clearance, none of the
organs that had shown elevated total Ag concentrations re-
covered to control levels, with at least one third or more of
the total Ag remaining in the organs of fish from both the
AgNO3 and Ag NP treatments (Table 1). The Ag2S treatment
showed a similar pattern of decreasing total Ag concentra-
tions in the organs in the post exposure phase, but with a
few crucial differences. Unlike the other treatments, the kid-
ney (P = 0.029) showed statistically significant decreases in
the total Ag concentrations at week 6 (two-way ANOVA); and
in the case of the gill, carcass and the blood, the total Ag
returned to control levels (below the detection limit); likely
because these compartments had only accumulated a small
amount of total Ag in the first place.
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Table 1 The concentration of total silver in the tissues (μg g−1 dry weight) and blood (ng mL−1) of rainbow trout following 4 weeks of exposure to a
control or 100 mg kg−1 Ag as either AgNO3, Ag NPs or Ag2S NPs
Tissue Week 1 Week 2 Week 3 Week 4 Week 6
Mid intestine
Control <LOD <LOD <LOD <LOD <LOD
AgNO3 6.33 ± 1.80
Aab 8.31 ± 1.04Aab 11.86 ± 2.52Aa 12.77 ± 3.30Aab 4.79 ± 1.72Ab
Ag NPs 3.24 ± 0.51Aa 5.65 ± 1.15Aab 12.48 ± 3.13Ab 10.08 ± 1.60Aab 12.19 ± 4.15Aab
Ag2S NPs 0.24 ± 0.04
Ba 0.17 ± 0.03Ba 0.22 ± 0.05Ba 0.21 ± 0.05Ba <LOD
Hind intestine
Control 0.05 ± 0.01Aa 0.04 ± 0.01Aa 0.04 ± 0.00Aa 0.02 ± 0.01Aa 0.04 ± 0.01Aa
AgNO3 61.38 ± 6.12
Bab 62.35 ± 6.62Bab 85.59 ± 10.37Bab 140.02 ± 22.38Ba 52.88 ± 10.55Bb
Ag NPs 35.55 ± 5.20Ba 65.15 ± 3.19Ba 70.43 ± 7.16Ba 89.87 ± 13.61Ba 46.36 ± 8.19Ba
Ag2S NPs 1.92 ± 0.29
Ca 1.15 ± 0.22Ca 1.12 ± 0.26Ca 0.46 ± 0.09Cb 0.04 ± 0.01Ac
Liver
Control 0.28 ± 0.02Aab 0.23 ± 0.01Aa 0.45 ± 0.06Ab 0.44 ± 0.03Ab 0.53 ± 0.06Ac
AgNO3 7.27 ± 1.02
Ba 79.76 ± 11.52Bb 89.43 ± 5.93Bb 121.77 ± 9.58Bb 113.33 ± 23.66Bb
Ag NPs 5.65 ± 0.57Ba 64.50 ± 6.40Bb 85.03 ± 11.86Bbc 128.63 ± 17.41Bc 87.67 ± 4.08Bbc
Ag2S NPs 1.98 ± 0.31
Ca 4.46 ± 0.68Cb 7.71 ± 0.94Cc 10.93 ± 0.95Cc 10.41 ± 2.15Cc
Gallbladder
Control <LOD <LOD <LOD <LOD <LOD
AgNO3 10.60 ± 3.18
Aa 34.08 ± 9.18Aa 20.66 ± 3.56Aa 19.13 ± 3.25Aa 6.62 ± 2.31Aa
Ag NPs 15.60 ± 4.11Aa 14.64 ± 1.69Aa 22.84 ± 4.97Aa 39.79 ± 14.41Aa 10.37 ± 4.02Aa
Ag2S NPs 0.17 ± 0.06
Ba 0.64 ± 0.11Ba 1.01 ± 0.20Ba 0.94 ± 0.33Ba 0.26 ± 0.13Ba
Kidney
Control <LOD <LOD <LOD <LOD <LOD
AgNO3 2.17 ± 0.31
Aa 8.68 ± 1.54Abc 8.32 ± 1.07Ab 23.59 ± 3.76Abc 24.77 ± 4.95Ac
Ag NPs 3.24 ± 0.75Aa 7.16 ± 1.80Aab 8.87 ± 1.95Abc 23.01 ± 6.59Acd 31.16 ± 8.05Ad
Ag2S NPs 0.12 ± 0.04
Ba 0.19 ± 0.04Bab 0.76 ± 0.26Bb 0.37 ± 0.11Bb 0.14 ± 0.06Ba
Spleen
Control <LOD <LOD <LOD <LOD <LOD
AgNO3 0.28 ± 0.05
Aa 0.54 ± 0.09Aab 0.68 ± 0.07Aab 1.24 ± 0.21Ab 0.64 ± 0.10Aab
Ag NPs 0.24 ± 0.00Aa 0.49 ± 0.11Aa 0.71 ± 0.17Aab 1.94 ± 0.57Ab 2.31 ± 0.80Bb
Ag2S NPs <LOD <LOD <LOD <LOD <LOD
Gill
Control <LOD <LOD <LOD <LOD <LOD
AgNO3 0.73 ± 0.32
Aa 0.75 ± 0.12Aa 0.83 ± 0.11Aa 1.30 ± 0.28Aa 0.35 ± 0.09Aa
Ag NPs 0.55 ± 0.06Aa 0.63 ± 0.10Aa 0.92 ± 0.12Aa 1.66 ± 0.30Aa 0.63 ± 0.08Aa
Ag2S NPs 0.14 ± 0.06
Bab 0.05 ± 0.01Ba 0.77 ± 0.43Bb 0.03 ± 0.01Ba <LOD
Brain
Control <LOD <LOD <LOD <LOD <LOD
AgNO3 0.46 ± 0.06
Aa 0.84 ± 0.12Aab 1.08 ± 0.19Abc 1.53 ± 0.13Ac 1.08 ± 0.20Abc
Ag NPs 0.43 ± 0.06Aa 0.57 ± 0.05Aab 1.02 ± 0.11Abc 1.57 ± 0.28Ac 1.05 ± 0.14Abc
Ag2S NPs <LOD 0.04 ± 0.00
Ba 0.07 ± 0.02Ba 0.02 ± 0.00Ba 0.04 ± 0.01Ba
Carcass
Control <LOD <LOD <LOD <LOD <LOD
AgNO3 1.01 ± 0.21
Aa 1.11 ± 0.17Aa 1.19 ± 0.14Aa 2.02 ± 0.35Aa 0.17 ± 0.02Ab
Ag NPs 1.21 ± 0.42Aa 1.01 ± 0.17Aa 1.33 ± 0.23Aa 2.05 ± 0.23Aa 0.26 ± 0.07Ab
Ag2S NPs 0.08 ± 0.03
Ba 0.16 ± 0.05Ba 0.26 ± 0.08Ba 0.17 ± 0.04Ba <LOD
Blood
Control N/A <LOD N/A <LOD <LOD
AgNO3 N/A 249.76 ± 29.71
Aa N/A 268.59 ± 17.28Aa 36.93 ± 4.18Aa
Ag NPs N/A 225.33 ± 13.70Aa N/A 260.61 ± 20.97Aa 54.97 ± 5.74Aa
Ag2S NPs N/A 9.57 ± 2.21
Ba N/A 21.39 ± 11.78Ba <LOD
Data are means ± S.E.M., n = 5/6. Limit of detection (LOD) of organs ranged from 0.8 to 25 ng g−1 dry weight. The LOD in whole blood samples
was 5.2 ng mL−1. N/A indicates no sampling at that time point occurred. Different upper case letter denotes statistical difference between
treatments within the same week (i.e., treatment effect within tissue by columns). Different lower case letters denotes statistical difference
between weeks within the same treatment (i.e., time-effect within rows). Data were analysed using a two-way ANOVA or Kruskal–Wallis. Note,
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Body burden and distribution of Ag for AgNO3, Ag NP and
Ag2S NP treatments
The calculated body distribution in the animals at the end of
the exposure and the end of the depuration phase are shown
(Table 2). The Ag body distribution for the control treatment
was not calculated because several organs were below the
limit of detection. At the end of the 4 week exposure, the Ag
body distribution in the AgNO3 treatment was as expected
with the organs containing a percentage of body burden in
the following order: carcass > liver > hind intestine > kidney
> gallbladder > mid intestine > gill > brain > spleen. Criti-
cally, the liver contained around two fifths of the body bur-
den. For the Ag NP treatment, the profile of the body burden
was similar to the AgNO3 treatment and in the order: carcass
> liver > hind intestine > kidney > gallbladder > mid intes-
tine > gill > brain > spleen. There was no significant differ-
ence between the body burden of any organ in the AgNO3
and Ag NP treatments (two-way ANOVA or Kruskal–Wallis; P
> 0.05). Small changes were found in the order of the distri-
bution of the body burden in the Ag2S NP treatment with:
carcass > liver > kidney > hind intestine > gallbladder > gill
> mid intestine > brain > spleen. However, the organs that
accounted for the majority of the body burden remained the
carcass, liver, kidney and hind intestine (>99% of the total),
similar to the AgNO3 and Ag NP treatments (98 and 97% of
the total, respectively).
After the depuration period (week 6), there was some evi-
dence of redistribution of the body burden in the AgNO3
treatment (Table 2). For example, there was a 4-fold reduc-
tion in the proportion of the body burden associated with the
carcass (two-way ANOVA; P < 0.001); this was complemented
by a significant rise in the kidney (2.4-fold; P = 0.003) and
liver (1.7-fold; P < 0.001). The predominant organ of Ag con-
tamination became the liver (66% of the body burden). This
pattern of re-distribution of the body burden from the car-
cass to the kidney and liver was also observed in the Ag NP
and Ag2S NP treatments.
Growth, food intake and mortality
The fish weighed around 10 g at the start of the experiment
and growth was steady with around a 4-fold increase in
weight over the 6 week period. At the start of each week,
there was no significant difference (one-way ANOVA's) be-
tween the average fish weight per treatment (P > 0.05), or the
Table 2 Total absolute amount of total Ag and the percentage of body burden within each organ
Tissue Treatment
Week 4 Week 6
Amount Ag (ng) % body burden Amount Ag (ng) % body burden
Mid intestine AgNO3 126.1 ± 46.6 0.47 ± 0.18
Aa 188.5 ± 77.5 1.51 ± 0.38Aa
Ag NPs 81.6 ± 18.0 0.35 ± 0.04Aa 266.4 ± 85.4 2.30 ± 0.81Aa
Ag2S NPs 2.2 ± 0.7 0.13 ± 0.05
Ba 0.2 ± 0.0 0.02 ± 0.00Bb
Hind intestine AgNO3 2022.7 ± 760.8 9.80 ± 3.98
Aa 1591.1 ± 213.2 11.52 ± 2.59Aa
Ag NPs 1295.7 ± 413.4 5.27 ± 1.31Aa 1601.8 ± 275.8 12.20 ± 2.16Aa
Ag2S NPs 17.4 ± 9.6 0.90 ± 0.37
Ba 1.8 ± 0.6 0.17 ± 0.03Bb
Liver AgNO3 7343.5 ± 515.5 38.25 ± 3.05
Aa 10 615.4 ± 2407.4 65.90 ± 5.10Ab
Ag NPs 8327.7 ± 947.5 38.38 ± 4.07Aa 9200.4 ± 1033.8 62.89 ± 2.16Ab
Ag2S NPs 907.2 ± 68.4 44.44 ± 5.34
Aa 937.8 ± 180.2 98.88 ± 0.37Bb
Gallbladder AgNO3 137.8 ± 68.7 0.84 ± 0.50
Aa 78.7 ± 32.7 0.51 ± 0.16Aa
Ag NPs 194.9 ± 20.0 0.95 ± 0.18Aa 88.6 ± 28.1 0.64 ± 0.22Aa
Ag2S NPs 10.5 ± 4.7 0.59 ± 0.34
Aa 4.6 ± 3.4 0.39 ± 0.26Aa
Kidney AgNO3 760.9 ± 132.9 3.88 ± 0.62
Aa 1096.8 ± 266.3 9.01 ± 1.63Ab
Ag NPs 966.1 ± 190.1 4.16 ± 0.65Aa 1517.1 ± 317.5 9.25 ± 0.90Ab
Ag2S NPs 59.2 ± 45.3 3.11 ± 2.16
Aa 5.4 ± 2.3 0.46 ± 0.12Ba
Spleen AgNO3 8.2 ± 1.5 0.04 ± 0.01
Aa 5.4 ± 1.0 0.05 ± 0.01Aa
Ag NPs 10.6 ± 4.1 0.04 ± 0.01Aa 16.7 ± 5.5 0.09 ± 0.02Aa
Ag2S NPs <LOD 0.00 ± 0.00 <LOD <LOD
Gill AgNO3 67.9 ± 29.6 0.33 ± 0.12
Aa 12.8 ± 2.4 0.11 ± 0.02Aa
Ag NPs 89.5 ± 45.3 0.34 ± 0.14Aa 32.5 ± 12.1 0.28 ± 0.15Aa
Ag2S NPs 3.7 ± 2.7 0.19 ± 0.13
A <LOD <LOD
Brain AgNO3 21.4 ± 2.5 0.11 ± 0.01
Aa 22.0 ± 4.4 0.19 ± 0.03Aa
Ag NPs 25.2 ± 6.6 0.11 ± 0.02Aa 18.3 ± 1.9 0.13 ± 0.02Aa
Ag2S NPs 0.9 ± 0.1 0.05 ± 0.01
Ba 0.7 ± 0.1 0.09 ± 0.02Ab
Carcass AgNO3 10 606.8 ± 2053.5 46.28 ± 3.77
Aa 1442.0 ± 256.9 11.21 ± 1.48Ab
Ag NPs 11 663.8 ± 1739.9 50.41 ± 2.80Aa 1968.2 ± 378.6 12.23 ± 1.20Ab
Ag2S NPs 942.1 ± 225.7 50.58 ± 4.92
A <LOD <LOD
Data are mean ± S.E.M. (n = 5/6). Blood Ag was not included in body distribution % (not taken from the same individual fish so not valid
comparison). Control fish are excluded for clarity due to small signals in the hind intestine and liver tissues. Note, the exposure phase was
until the end of week 4, followed by two further weeks on normal food to week 6. Statistical analysis was only performed on the % body
burden (two-way ANOVA or Kruskal–Wallis) for treatment and time. Different upper case letter denotes statistical difference between
treatments within the same week (i.e., treatment effect within tissue by columns). Different lower case letters denotes statistical difference
between weeks within the same treatment (i.e., time-effect within rows). Statistical analysis not performed on the mass of Ag in the tissue as
this is not standardised data with respect to organ weight.
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weekly cumulative food intake (P > 0.05; Fig. 1). Over the
course of the study, there was a total loss of seven fish. Due
to the mortalities being spread over five tanks across all treat-
ment, and the presence of fin lesions from observable bully-
ing (a normal aggressive behaviour of trout); these were not
attributed to treatment related effects.
Blood plasma and tissue electrolyte concentration
The plasma Na+ and K+ concentration were measured from
all treatments (Table S1†). The plasma Na+ showed a tran-
sient decrease at week 4 in the AgNO3 treatment, but this
was close to the normal physiological range, and overall there
was no statistically significant differences from the other
treatments (P > 0.05). There were some time and treatment
related effects in the plasma K+ concentrations (two-way
ANOVA; Table S1†), but these were also transient and within
the normal range. For example, after 4 weeks of exposure, the
plasma K+ concentrations in the Ag2S NP treatment was sig-
nificantly elevated to 2.8 mmol L−1 compared to only 1.8
mmol L−1 in the control (P = 0.014). However, overall there
was no nanomaterial-type effects on either Na+ or K+ concen-
trations, and after the depuration period there was no signifi-
cant differences between treatments (two-way ANOVA; Na+, P
> 0.05, K+, P > 0.05).
The tissue electrolyte concentrations showed only small
transient changes between treatments (one-way ANOVA or
Kruskal–Wallis; Table S2†). For example, the Na+ concentra-
tion in the hind intestine of the AgNO3 treatment was signifi-
cantly lower (1.83 mg g−1) compared to that for the control
(3.13 mg g−1; P = 0.032), Ag NP (3.59 mg g−1; P = 0.004) and
Ag2S NP treatments (2.99 mg g
−1; P = 0.041). There was no
nanomaterial-type effects. The moisture content of the tissue
(data not shown) ranged between 69 and 84%, depending on
the type of tissue. There was no significant difference be-
tween the treatments (one-way ANOVA or Kruskal–Wallis; P >
0.05).
Histological examination and biochemical alterations
There were no major histological changes to the mid intes-
tine (Fig. 2) or hind intestine (not shown) after 4 weeks of
exposure. The mucous epithelium showed normal morphol-
ogy. There was no evidence of erosion of the tips of the villi
and the tissue showed normal columnar epithelial cells
without foci of necrosis or reactive hyperplasia. The
mucocytes in the epithelial also appeared normal, with no
evidence of mucocyte proliferation. The average size of the
mucocytes in the mid intestine were 19.2 ± 1.2, 19.8 ± 1.5,
19.8 ± 1.8 and 17.5 ± 0.9 μm in the control, AgNO3, Ag NP
and Ag2S NP treatments, and there was no significant differ-
ence (one-way ANOVA) between treatments (P = 0.733). Addi-
tionally, there was no evidence of pathology to the gills of
the Ag treatments or controls, with the absence of oedema
in the tips of the secondary lamellae and no evidence of ne-
crosis in the epithelium, or evidence of mucocyte prolifera-
tion. The vasculature in the gill appeared normal without
aneurisms or evidence of swollen red blood cells. Overall,
the normal gill morphology indicated the absence of water-
borne exposure to silver.
There were no treatment-related differences in the total
GSH concentration of the liver, brain, mid intestine, hind in-
testine or kidney by the end of the exposure (one-way ANOVA
or Kruskal–Wallis; Fig. 3). However, there was a small, but
statistically significant decrease in total GSH concentration
in the gill in the AgNO3 treatment compared to the Ag NP
treatment only (P = 0.023), but these effects were not signifi-
cantly different from the control fish. There were no differ-
ences in total GSH between the Ag NP and Ag2S NP treat-
ments at the end of the exposure phase.
There was no change to TBARS concentration of the gill,
brain, kidney or liver tissues at the end of the exposure phase
(one-way ANOVA or Kruskal–Wallis; Fig. 3). However, some
small changes were observed in the intestine (Kruskal–Wal-
lis). The mid intestine of the control fish had a TBARS con-
centration of 3.1 ± 0.3 nmol TBARS mg−1 protein, whereas
the Ag NP and Ag2S NP treatments had 1.4 ± 0.1 and 1.3 ± 0.2
Fig. 1 Average body weight (A) and cumulative food intake (B) in
rainbow trout fed a control diet (no added Ag) or diets containing 100
mg kg−1 of Ag as either AgNO3, Ag NPs or Ag2S NPs for 4 weeks, then
with two weeks recovery on normal (control) food. There was no
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nmol TBARS mg−1 protein. A one-way ANOVA revealed the
Ag2S NP treatment was significantly lower compared to the
control (P = 0.030) but the Ag NP treatment was not (P =
0.057). Within the hind intestine, there was a trend of de-
creasing TBARS concentration in all the Ag treatments com-
pared to the controls (the latter, 2.1 ± 0.4 nmol TBARS mg−1
protein), but of these only the Ag NP treatment was signifi-
cantly reduced compared to the controls (P < 0.001). There
were no material-type effects.
In chemico digestibility assay
The in chemico digestibility assay was used to identify any po-
tential labile fraction of dissolved silver from the experimen-
tal diets at pH 2 to represent the stomach (Fig. 4). There was
no detectable dissolution from the control or Ag2S NPs (be-
low the procedural LOD of 2.3 ng g−1). However, there was
some release of dissolved Ag from the AgNO3 and Ag NP diets
with both time- and treatment-related differences (two-way
ANOVA). There was a rapid elevation of dissolved Ag
appearing in the external compartment of the test vessel over
the 4 hour incubation, with the total Ag (ng) released per g of
food approximately doubling between each time interval, in
both treatments (Fig. 4). There was significantly more total
Ag released from the food pellets containing Ag NPs com-
pared to those with AgNO3 after 1 h (P = 0.040), 2 h (P <
0.001) and 4 h (P < 0.001). There was no detectable dissolu-
tion in the intestinal simulations at pH 7.8 (<LOD, data not
shown).
Discussion
This study has demonstrated that rainbow trout will eat diets
contaminated with a nominal 100 mg kg−1 of Ag as AgNO3,
Ag NPs or Ag2S NPs without effects on growth or overt toxic-
ity. The ingested silver subsequently caused total silver
Fig. 2 Transverse histological sections of the mid intestine (left) and
sections of gills (right) following 4 weeks exposure to control (no
added Ag; A and E), or 100 mg kg−1 of Ag as AgNO3 (B and F), Ag NPs
(C and G) or Ag2S NPs (D and H). The mid intestine was stained using
haematoxylin/alcian blue/van Gieson's to highlight collagen (red),
mucins (blue/turquoise), muscle and red blood cells (yellow),
cytoplasm (pink/yellow) and nuclei (black/brown). The gills were
stained with Mallory's trichrome. Note the absence of pathology in the
gill for the dietary exposure, and the normal gross anatomy of the
intestine with mucocytes.
Fig. 3 Total GSH (A) and TBARS (B) concentrations following 4 week
exposure to the control (no added Ag) or 100 mg kg−1 Ag as either
AgNO3, Ag NPs or Ag2S NPs. Data are mean ± S.E.M (n = 5/6). Different
upper case letters denote statistical difference between treatments
within the same organ. Data points with no letters indicate no
statistically significant effect in that organ.
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accumulation (form unknown) in the internal organs includ-
ing the liver, kidney, brain, and the blood supply. Where ac-
cumulation was observed, the internal organs generally
showed a gradual increase in accumulation over time, and
with either partial or negligible decreases in the organ con-
centrations during the depuration phase, suggesting only a
slow clearance from the body. As a proportion of the body
burden, the liver showed the greatest organ accumulation for
all treatments, and in keeping with the organ's role as a cen-
tral compartment in processing metals. While the target or-
gans and pattern of total Ag accumulation was broadly simi-
lar for dietary exposure to AgNO3 and Ag NPs, the Ag2S often
caused less total Ag accumulation in the internal organs,
suggesting the latter nanomaterial was less bioavailable.
Dietary exposure and total silver accumulation
It is well known that fish will eat food contaminated with
metals (review, Handy et al.6), including Ag,3 usually without
mortality. This was also the case in the present study where
only a few fish mortalities were observed (in random tanks),
and regardless of the form of Ag added to the food, the ani-
mals continued to feed and gain body weight (Fig. 1). Dietary
Ag exposure was confirmed by the measured total Ag in the
food and by carefully monitoring the food intake during the
experiment. Incidental waterborne exposure is unlikely be-
cause the measured total metal concentrations in the water
were at trace levels or below the detection limit and there
was no evidence of the gill pathology (e.g., no oedema, no ep-
ithelial lifting) that is normally associated with dissolved
metal toxicity. There was also no overt pathology in the intes-
tines (Fig. 2), and overall the exposure can be regarded as a
sub-lethal event leading to a physiologically relevant pattern
of total Ag accumulation in the internal organs.
The unexposed control fish showed either trace amounts
of total Ag in the organs (<1 μg g−1 dw) or were below detec-
tion, in keeping with previous reports of background Ag in
trout.3 The dietary exposure to food containing AgNO3 also
resulted in the expected pattern of Ag accumulation, with the
total Ag accumulating primarily in the intestine and liver
compared to unexposed controls, and consistent with the
route of exposure. Some total Ag was also detected in the kid-
ney and blood, but not much in the gills of fish fed food
containing AgNO3; similar to Galvez et al.
3 There appears to
be no in vivo reports of dietary exposure to food pellets
containing Ag NPs in rainbow trout. The present study
showed a pattern of total Ag accumulation (form unknown)
in the organs which was very similar to that of the AgNO3
treatment; both in terms of the target organs and the total Ag
concentrations achieved in those organs at the end of the ex-
posure phase (Table 1). The distribution of the Ag body bur-
den was also identical between AgNO3 and Ag NP treatments.
This suggests the bioaccumulation hazard from dietary
AgNO3 and Ag NPs are the same. Recently, Kleiven et al.
25 ex-
posed Atlantic salmon to ∼60 mg Ag kg−1 as either 110AgNO3
or as citrate-coated or uncoated 110Ag NPs in a slurry, admin-
istered by oral gavage. After two days of exposure, the radio-
activity from the AgNO3 and citrate-coated Ag NPs oral treat-
ment, was associated with the liver, but not the gills;25
similar to the findings in the present study with total Ag.
However, Kleiven et al.25 also noticed that radioactivity
from the uncoated Ag NPs was transferred less to the liver
than the citrate-coated Ag NPs. This suggests the form of the
nanomaterial is important to the accumulation pattern. In
the present study, the Ag2S treatment generally showed less
total Ag accumulation in the internal organs than that of the
Ag NPs after four weeks of exposure (Table 1). An in chemico
digestibility assay on the same food used in the present
study,1 showed that total Ag from the Ag2S-containing pellets
was less extractable and therefore would have lower bioavail-
ability in the gut lumen. This is in keeping with the in vivo
findings here. However, bioavailability in the gut lumen may
not be the only factor that determines Ag accumulation in
the internal organs. From a chemistry perspective, Ag2S NPs
are regarded as persistent and if they remain inert in biologi-
cal media, then perhaps they might be less bioaccessible for
uptake by the tissues. It is interesting that Kleiven et al.25
found that the radioactivity in the intestine (∼700, 900 and
700 corrected counts per minute per g wet weight tissue, for
AgNO3, coated Ag NPs and uncoated Ag NPs, respectively)
were similar; and yet less of the radioactivity associated with
uncoated Ag NPs was found in the liver.
Depuration and redistribution of the body burden
There are only a few reports of depuration following Ag expo-
sures in fish, and these are for waterborne exposures.26,27
Nonetheless, these studies show, for dissolved silver at least,
that the uptake is relatively rapid over hours or a few days
and that depuration is slower, over weeks. The depuration
Fig. 4 Concentration of dissolved silver released from the diet under
acidic stomach conditions (pH 2). Data are means ± S.E.M., (n = 4).
Different upper case letters denote statistical difference between Ag
treatments. Different lower case letters denote statistical difference
between time points (two-way ANOVA). Note the control and Ag2S NP
treatments had no apparent release of total Ag (the procedural LOD
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phase has an initial exponential decrease in body silver con-
centrations and then a much slower fraction that persists
and is never cleared entirely.26 The dietary exposure to
AgNO3, here showed some broad similarity to these earlier
waterborne studies with regard to slow clearance. Apart from
some clearance from the blood and intestines, there was no
appreciable clearance of the body burden after two weeks on
normal food (Table 1). However, there was some redistribu-
tion of the total Ag towards the liver and kidney, presumably
to facilitate eventual excretion and/or inert storage of the to-
tal Ag. This was also observed in the Ag NP treatment, and to
a lesser extent in the Ag2S treatment (Table 1).
Unfortunately, while there have been reports of dietary up-
take of metal-containing ENMs in fish (TiO2,
15 ZnO,16 CdS
particles,17 gold particles,28 quantum dots29); only a few of
these studies also measured the carcass with the aim of cal-
culating the body distribution of the total metal. In the pres-
ent study at the end of the exposure phase, the liver
contained 38–44% of the Ag body burden, and regardless of
the type of material exposure, this increased to 63–99% after
two weeks on normal food (Table 2). This redistribution of
the total Ag to the liver, presumably for excretion, has not
been previously reported in trout for Ag NPs. The presence of
at least some Ag in the gallbladder (Table 1) suggests at least
some incidental Ag excretion (form unknown) into the bile
from the Ag NP dietary exposure, although the fraction was
less than 1% of the body burden (Table 2). At least one study
with Ag NPs on marine medaka (Oryzias melastigma) showed
retention of Ag from Ag NP dietary exposure,30 but compari-
sons with freshwater-adapted trout are problematic because
of the very different osmoregulatory strategies, renal func-
tion, and gut chemistries of marine and freshwater fish.
The kidney may also have a role in depuration and/or stor-
age of Ag (form unknown). The proportion of the body bur-
den in the kidney increased from 4% to 10% in the
depuration phase for the Ag NP treatment (Table 2). This
might imply some renal excretion of total Ag, or more likely,
that the normal macrophage activity in the kidney is
resulting in some Ag precipitation in the organ, as is known
for Cu NPs.23 The renal perfusion as a proportion of blood
flow is also relatively high in freshwater-adapted trout, so the
apparent retention by the kidney in the post-exposure phase
will inevitably include some total Ag that is in the blood in-
side the organ. Similar arguments of macrophage activity and
blood flow may also apply to the spleen where some total Ag
remains (Table 1). Interestingly, van der Zande et al.31 also
found that dietary Ag NP exposures in rodents resulted in to-
tal Ag accumulation in the internal organs with the most
blood flow, such as the liver, spleen, kidney, lung and brain.
The rodents also showed some clearance from the blood
post-exposure, but with a persistent residual of total Ag in
the internal organs, similar to the present study on trout
(Tables 1 and 2).
The internal organs of fish fed with Ag2S showed much
less total Ag accumulation than either of the other Ag treat-
ments. Consequently, the smaller amounts present were
sometimes cleared. For example, at the end of the experi-
ment, the blood and the gills were at the detection limit for
total Ag (Table 1); but otherwise the pattern for the
depuration phase was similar to the Ag NPs. However, on a
proportion of body burden basis, the carcass from the Ag2S
treatment cleared all the detectable total Ag compared to the
other treatments by week 6 (Table 2).
Growth, gut health and sub-lethal effects
One concern for dietary exposure to metals is the potential
for adverse effects on growth, nutritional performance, or on
the integrity of the gut epithelium. In the present study, there
were no effects of any of the Ag-containing treatments on cu-
mulative food intake or growth (Fig. 1). The intestines
showed some reductions in TBARS in the animals fed with
nanomaterials, but without total glutathione depletion in any
treatment (Fig. 3), and the intestinal morphology was normal
(Fig. 2). Together, this suggests the gut remained healthy, de-
spite the potential for some dissolved silver release in the
acidic conditions of the stomach (Fig. 4). There are only a
few in vivo reports of nutritional performance in rainbow
trout few diets containing added silver salts. Galvez and
Wood4 fed trout diets containing up to 3000 mg kg−1 of Ag as
Ag2S for 58 days with no significant differences in food in-
take, specific growth rate or food conversion efficiency; de-
spite clear Ag accumulation in the intestines. Galvez et al.3
made similar observations on growth and food intake with
trout fed 3.1 mg kg−1 of Ag over 126 days, where the Ag has
been biologically incorporated into trout meal used to make
the food pellets.
The absence of intestinal pathology with dietary AgNO3
(Fig. 2) is perhaps not surprising. The gut was well-defended
with intact mucous cells (Fig. 2), and the tissue depending
on the region of the gut in trout, typically contains between
100–500 μg g−1 wet weight of metallothionein;32 which to-
gether might readily chelate the maximum total Ag of around
140 μg g−1 found in the hind intestine (Table 1). There ap-
pears to be no reports of in vivo intestinal morphology in
trout fed dietary Ag NPs, but in zebrafish fed 500 mg kg−1 of
Ag NPs for 14 days there was no loss of integrity of the gut
epithelium or any damage to the microvilli on the apical sur-
face of the gut cells.33 Rats receiving a daily administration
of 3.6 mg kg−1 by gavage of cubic or spherical Ag NPs (20 mL
kg−1 body weight) for 14 days also showed no evidence of his-
tological disturbance to the stomach, small intestine, cecum
or colon.34
Exposure to dissolved silver via the water is known to
interfere with branchial sodium homeostasis in trout.35 How-
ever, dietary silver generally does not. Galvez et al.3 found no
effects of dietary Ag on Na+ influx or plasma Na+ in trout.
Similarly for the AgNO3 diet in the present study, there were
no effects on the total glutathione or TBARS in the gill
(Fig. 3), indicating negligible oxidative stress to this osmoreg-
ulatory organ. There were no effects on plasma Na+, and only
small changes in plasma K+ within the physiological range,
































































































Environ. Sci.: Nano This journal is © The Royal Society of Chemistry 2019
compared to controls (Table S1†). The major electrolytes in
the internal organs was also unaffected (Table S2†). The same
observations were made for dietary exposure to Ag NPs or
Ag2S NPs (Tables S1 and S2†). There were some statistically
significant disturbances to Cu concentrations in some organs
(Table S2†), and this was observed previously in dietary stud-
ies with TiO2 NPs in trout,
15 although the biological impor-
tance of small changes in tissue Cu is unclear. In the present
study, there was no evidence of oxidative stress in the inter-
nal organs (Fig. 3).
Conclusions and perspective on environmental hazard
assessment
In conclusion, the present study has demonstrated dietary ac-
cumulation of total Ag in trout arising from exposures to
food containing AgNO3, Ag NPs or Ag2S NPs. The data is
interpreted as sub-lethal, with physiologically relevant uptake
and without pathology to the gut or biochemical disturbances
to the internal organs. A key concern for environmental regu-
lation is whether ENMs present a different hazard to their
nearest equivalent metal salt. The present study showed the
dietary bioaccumulation of AgNO3 and Ag NPs to be equal,
with total silver from both of these materials (form unknown
in the tissue) being more bioavailable than total Ag arising
from the Ag2S NP treatment. The bioaccumulation potential
ranking would therefore be AgNO3 = Ag NPs > Ag2S NPs.
However, there is also a desire to reduce the use of animals
in the bioaccumulation testing strategy.1 Recently, our labo-
ratory used an alternative ex vivo gut sac technique for
assessing the total Ag accumulation by the gut in 4 hour in-
cubations using the same ENMs as the present study.20 The
gut sac approach is intended as a screening tool in a tiered
approach to bioaccumulation testing,1 and correctly identi-
fied a bioaccumulation concern for both AgNO3 and Ag-
containing ENMs in the gut tissue. The ex vivo gut sac results
gave a slightly different ranking of AgNO3 > Ag NPS = Ag2S
NPs.20 Regardless, both the in vivo and ex vivo findings on
these materials suggest the existing risk assessment for
dissolved silver would encompass the bioaccumulation po-
tential risk of the nano forms (i.e., no additional risk from
nano). In both studies, the most likely of the nano forms to
be released into the environment, the Ag2S NPs, was identi-
fied as less hazardous than AgNO3. However, further work is
needed to understand how the food matrix can effect dietary
bioavailability of ENMs and to determine if ENMs can be-
come ‘biologically incorporated’ into the tissues in a similar
fashion to dissolved metals. The human health risk from the
total silver accumulated in the carcass (i.e., mostly the edible
flesh) also needs to be considered, and work is underway to
validate a detection method for nano forms and particle size
distributions in the internal organs of trout.
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